Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a product name.
REQUEST A FREE TRIAL
Product
Deals
Articles
BioCentury
|
Feb 3, 2025
Guest Commentary
Rebuilding trust in FDA through labeling clarity and transparency
Regulatory agency must be proactive in fighting the surge in skepticism about the drugs and vaccines it regulates
Read More
BioCentury
|
May 10, 2023
Deals
May 9 Quick Takes: Roche taps Zion for brain-penetrating HER2 program
Plus: Gilead acquires XinThera, Amgen partners with TScan and updates from Ascend, Novavax, Gilead and more
Read More
BioCentury
|
Jun 24, 2022
Regulation
June 23 Quick Takes: FDA unveils neurogenerative disease action plan
Plus FDA places hold on Sarepta DMD trial and updates from Novartis, uniQure, DermBiont, Valneva and more
Read More
BioCentury
|
Feb 26, 2020
Product Development
Regulatory Roundup: FDA reviewing GSK, Takeda applications for earlier lines of cancer treatment; plus Novartis, Halozyme-Genentech, MacroGenics, CSL, Lilly
Read More
BioCentury
|
May 12, 2016
Targets & Mechanisms
Another shot at the flu
Targeting caspases may prevent flu-associated death in the elderly
Read More
BioCentury
|
Dec 7, 2015
Clinical News
Fluad regulatory update
Read More
BioCentury
|
Nov 26, 2015
Clinical News
FDA approves adjuvanted seasonal flu vaccine
Read More
BioCentury
|
Jul 27, 2015
Clinical News
Fluad regulatory update
Read More
BioCentury
|
Feb 9, 2015
Clinical News
Fluad Pediatric regulatory update
Read More
BioCentury
|
Dec 15, 2014
Clinical News
Fluad regulatory update
Read More
Items per page:
10
1 - 10 of 25
Help Center
Username
Request Training
Submit Data Correction
Ask a Question
Elevio by Dixa
Help